Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever

Clinical Infectious Diseases

Volumn 43, Issue 8, 2006, Pages 1023-1030

  Wang, Wei Kung ^a,c   Chen, Hui Ling ^a   Yang, Chao Fu ^a   Hsieh, Szu Chia ^a   Juan, Chung Chou ^e   Chang, Shu Mei ^e   Yu, Cheng Ching ^f   Lin, Li Hui ^f   Huang, Jyh Hsiung ^d   King, Chwan Chuen ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CENTER FOR DISEASE CONTROL   (Taiwan)

^e YUAN'S GENERAL HOSPITAL   (Taiwan)

^f Hui Te Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C5A; CYTOKINE; INTERLEUKIN 2 RECEPTOR; VIRUS RNA;

ADULT; AGED; ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE SHOCK SYNDROME; DENGUE VIRUS; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIC; FATALITY; FEMALE; FEVER; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SUPERINFECTION; TAIWAN; VIRUS LOAD; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGEN-ANTIBODY COMPLEX; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; FEMALE; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; VIRAL LOAD;

EID: 33750295473     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/507635     Document Type: Article

References (45)

1. Monath TP. Dengue, the risk to developed and developing countries. Proc Natl Acad Sci U S A 1994; 91:2395-400.
2. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. TRENDS Microbiol 2002; 10:100-3.
3. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2:33-42.
4. World Health Organization (WHO). Dengue hemorrhagic fever, diagnosis, treatment and control. 2nd ed. Geneva: WHO, 1997.
5. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239:476-81.
6. Halstead SB, O'Rourke EJ. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977; 265:739-41.
7. Morens DM, Venkateshan CN, Halstead SB. Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune enhancement of dengue 2 viruses. J Gen Virol 1987; 68:91-8.
8. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors for dengue shock syndrome: a prospective epidemiologic in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984; 120:653-69.
9. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172-80.
10. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 1990; 42:179-84.
11. Gubler DJ, Reed D, Rosen L, Hitchcock JC. Epidemiologic, clinical and virologic observations on dengue in the kingdom of Tonga. Am J Trop Med Hyg 1978; 27:581-9.
12. Leitmeyer KC, Vaughn DW, Watts DM, et al. Dengue virus structural differences that correlate with pathogenesis. J Virol 1999; 73:4738-47.
13. Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 2003; 9:880-9.
14. Rosen L. The emperor's new clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26:337-43.
15. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2-9.
16. Murgue B, Roche C, Chungue E, Deparis X. Prospective study of the duration of magnitude of viremia in children hospitalized during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 2000; 60:432-8.
17. Libraty DH, Endy TP, Houng HS, et al. Differing influence of virus burden and immune activation on disease severity in secondary dengue-3 virus infection. J Infect Dis 2002; 185:1213-21.
18. Sobel AT, Bokisch VA, Muller-Eberhand HJ. C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum. J Exp Med 1975; 142:139-50.
19. Theofilopoulos AN, Wilson CB, Dixon FJ. The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest 1976; 57:169-82.
20. Ruangjirachuporn W, Boonpucknavig S, Nimmanitya S. Circulating immune complexes in serum from patients with dengue hemorrhagic fever. Clin Exp Immunol 1979; 36:46-53.
21. Bokisch VA, Top FH, Russell PK, Dixon FJ, Muller-Eberhard HJ. The potential role of complement in dengue hemorrhagic shock syndrome. N Engl J Med 1973; 289:996-1000.
22. Muller-Eberhard HJ, Dixon FJ, Tuchinda P, Bukkavesa S, Suvatte V. Pathogenic mechanisms in dengue hemorrhagic fever: report of an international collaborative study. Bull WHO 1973; 48:117-33.
23. Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infection. J Clin Invest 1991; 88:1473-80.
24. Green S, Vaughn DW, Kalayanarooj S, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 1999; 59:329-34.
25. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179:755-62.
26. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999; 257:1-6.
27. Wang WK, Chao DY, Kao CL, et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 2003; 305:330-8.
28. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997; 176:322-30.
29. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-51.
30. Shu PY, Chen LK, Chang SF, et al. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol 2003; 10:622-30.
31. Wang WK, Sung TL, Tsai YC, Kao CL, Chang SM, King CC. Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay. J Clin Microbiol 2002; 40:4472-8.
32. Thein S, Aaskov J, Myint TT, Shwe TN, Saw TT, Zaw A. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. J Med Virol 1993;40:102-6.
33. Vaughn DW, Nisalak A, Solomon T, et al. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 1999; 60:693-8.
34. Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176:313-21.
35. Churdboonchart V, Bhamarapravati N, Peampramprecha S, Sirinavin S. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg 1991; 44:481-93.
36. Libraty DH, Young PR, Pickering D, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002; 186:1165-8.
37. Piatak, M, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined. Science 1993; 259:1749-54.
38. Mathew A, Kurane I, Green S, et al. Impaired T cell proliferation in acute dengue infection. J Immunol 1999; 162:5609-15.
39. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003; 9:921-7.
40. Raymond M, Rothman AL. Dengue immune response: low affinity, high febrility. Nat Med 2003; 9:820-2.
41. Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998; 394:482-5.
42. Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A. Viremia in patients with naturally acquired dengue infection. Bull WHO 1981; 59:623-30.
43. Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979; 140:527-33.
44. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38:411-9.
45. Igarashi T, Brown C, Azadegan A, et al. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat Med 1999; 5:211-6.